Across TCGA pan-cancer cohorts, FER1L6 mass-spec protein differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of FER1L6’s most consistent transcriptional readouts.
The strongest signal is observed in colon adenocarcinoma (COAD), where FER1L6 mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types FER1L6 is over-expressed in tumor, although a few such as COAD show the opposite, repressed pattern.
COAD and LUAD are the cancer types where FER1L6 tumor–normal differential expression is most reproducible.